Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis
about
MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic SclerosisRecent developments in myofibroblast biology: paradigms for connective tissue remodelingMolecular pathogenesis of skin fibrosis: insight from animal models.A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosisDifferential expression of extracellular matrix-mediated pathways in single-suture craniosynostosisRole of canonical Wnt signaling/ß-catenin via Dermo1 in cranial dermal cell development.Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome.Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?Imbalance of Wnt/Dkk negative feedback promotes persistent activation of pancreatic stellate cells in chronic pancreatitis.Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes.Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesiclesThymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β.Dermal β-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation.Fibrosis in systemic sclerosis: common and unique pathobiology.Fibrillin-containing microfibrils are key signal relay stations for cell function.Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca(2+) release channel.TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.Collagen content in skin and internal organs of the tight skin mouse: an animal model of sclerodermaβ-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.Paracrine Secreted Frizzled-Related Protein 4 Inhibits Melanocytes Differentiation in Hair Follicle.Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.Scleroderma therapy: clinical overview of current trends and future perspective.Morphogen pathways in systemic sclerosis.Systemic effects of Wnt signaling.Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?Novel investigational agents for the treatment of scleroderma.Integrins and cadherins as therapeutic targets in fibrosis.Current frontiers in systemic sclerosis pathogenesis.Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays.The molecular pathogenesis of morphoea: from genetics to future treatment targets.Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.Connective tissue disease: SSc-fibrosis takes flight with Wingless inhibition.Sustained β-catenin activity in dermal fibroblasts is sufficient for skin fibrosis.Secreted frizzled related protein 4 reduces fibrosis scar size and ameliorates cardiac function after ischemic injury.Towards embryonic-like scaffolds for skin tissue engineering: identification of effector molecules and construction of scaffolds.Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
P2860
Q26781257-CFEF4209-C011-4B1A-9B9B-501FF9091A3AQ26863751-450FB7C1-3748-490A-AAFE-7D19DE2469E3Q33819183-8C56D016-055B-4B30-9718-773D30C5EB80Q33923580-4273C2BE-81B2-4423-814F-46B3A12DC340Q34058672-3C06148B-9321-4658-89CA-637E5832F0BCQ34290550-FD4DB046-FAB0-465D-8D47-B41BEBBD2E87Q34315290-47EBC0D4-B0E1-478B-A409-654F699D76AAQ34765727-753C1AE0-000F-4C2D-82B5-09E22CE15926Q35072458-F2BE0F34-0CAF-4355-B386-7F0C169B1D79Q35152912-E4140B2F-5475-4470-8BFA-D4B56AB76498Q35171136-9D957E80-7FE0-4CD0-A41D-7DEB0EA4F97DQ35469264-FFF24D03-9588-4D73-B043-1FC893FBAC69Q35624119-30BEB9BC-3722-4DC0-AF8B-581C93A187E5Q35841035-4C3F4A2D-82D3-44ED-B69D-9CD6974537BCQ36012572-41861E0F-7CC7-4B5A-AC78-BEDE2D848BD0Q36470965-853040C5-832C-4640-869C-122CC1587C4AQ36527573-5BAF0746-DE72-4790-9A96-62F18350BCDFQ37100262-C2B79F01-EB4B-47A5-ADD6-70C33FD2139CQ37292131-9B650F03-372A-4F2F-B028-53E98F2FBE4BQ37634132-3C2D2483-F69B-495D-9359-EE9205C55669Q37638268-DE407C83-2537-44CF-BFB6-6595C97687CDQ37690207-7897AEC6-4FB9-4A3D-9DED-60157839BDBEQ37699901-DBFDC4D6-9510-4836-BF50-367FDC43FB52Q37721063-D7260C9A-6F3B-455A-8B55-897DBB7312A8Q38046467-B29516A0-4767-46D4-8465-79030052BCBAQ38071976-0AE76EA1-E130-4809-A96D-9616A06CFBADQ38077507-8D67850B-DA38-4393-98EC-CC218A3008ADQ38151902-A57E1F0A-4C69-4481-AA73-CF25AEA5638EQ38164818-8845CACC-4CB5-4266-8B5A-239C82EBA9F4Q38219401-40CEAE3B-720C-4748-9ED1-B3DD922249AEQ38364957-4019D2E4-D5BC-4FB0-A134-3876A5D341ACQ38497300-F5A4DA6C-570F-479B-B1DD-729D075F3035Q38828584-981A02CF-BF25-4C84-931C-AD11C7C8E0F0Q39945922-015E2D43-68B0-4266-9B1C-74C9A434F114Q40784686-C4F813C7-CF41-4BC9-B9AA-978C8C6CC0F0Q42133126-D88420B4-D3C4-4CAB-A827-8FCC12A337D1Q42158169-7E7E777D-AB4A-4F70-9260-FDEA3AA290D0Q42158760-46EB09C5-4DBB-416C-ABC3-14BDB9F5BC1BQ44449650-E4B42AFE-AE59-4268-A8DE-1C8D3F67E532Q48365002-5AB84A77-CA05-408E-9C6F-7C87F2F6F5B8
P2860
Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis
description
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Oktober 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/04/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/04/01)
@nl
наукова стаття, опублікована у квітні 2008
@uk
مقالة علمية (نشرت في أبريل 2008)
@ar
name
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@ast
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@en
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@nl
type
label
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@ast
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@en
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@nl
prefLabel
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@ast
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@en
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@nl
P2093
P356
P1476
Increased expression of Wnt2 a ...... osition and systemic sclerosis
@en
P2093
Jennifer Fitch
Julie Bayle
Kimberly Jacobsen
Rajiv Kumar
Raphaël Lemaire
P2888
P304
P356
10.1038/SJ.JID.5701101
P407
P577
2007-10-18T00:00:00Z
P5875
P6179
1032796600